ReviewRSC advances2025
Recent developments and future perspectives for photoresponsive-based gold nanoparticles (Au-NPs) and their biomaterial applications.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Fluorescent Chemosensors as Precision Tools for Bioimaging and Environmental Monitoring: Advances, Challenges, and Future Directions.Journal of fluorescence · 2026Review
- Controlled Self-Assembly of Gold Nanoparticles for Photo-Enhanced Cancer Imaging and Treatment.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Article
- PNVCL-Based Multifunctional Nanogels Loaded with Curcumin, 5-Fluorouracil, and Gold Nanorods: Their Performance in Colon Cancer Cells.Gels (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photoresponsive gold nanoparticles (AuNPs) represent a dynamic class of nanomaterials combining the optical tunability of gold with the reversible photochemistry of organic chromophores. Functionalisation with azobenzene, fluorescein, perylene, and pyrene derivatives enables light-controlled modulation of molecular conformation, fluorescence, and surface interactions. These hybrid systems have shown wide applicability in drug delivery, imaging, biosensing, and photothermal therapy. This review summarises recent advances in their design, synthesis, and biomedical integration, with emphasis on photoisomerisation dynamics, optical coupling, and structure-function relationships. Key challenges including limited light penetration, photostability, and clinical scalability are highlighted alongside emerging prospects such as NIR-responsive and multi-stimuli platforms. Photoresponsive AuNPs thus offer a promising foundation for next-generation light-regulated biomaterials and precision nanomedicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.